Research Examines Link Between Vitiligo and Systemic Sclerosis
Drug Topics
NOVEMBER 21, 2022
Israeli researchers find more than fivefold risk of developing systemic sclerosis among people with vitiligo.
Mon.Nov 21, 2022
528 
The 340B program is interfering with the U.S. biosimilars market and impacting patient costs
PhRMA
NOVEMBER 21, 2022
Research has shown that 340B hospitals are more likely to prescribe more expensive medicines and significantly mark up the price of medicines. For example, 340B hospitals received nearly five times what they paid, on average, to acquire oncology medicines through 340B. These practices have implications for what patients pay out of pocket — and new research adds to the evidence.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Flash Glucose Monitoring May Prompt Lifestyle Changes in Prediabetes
Drug Topics
NOVEMBER 21, 2022
New research indicates that glucose monitoring could lead to lifestyle changes during prediabetes.
In cancers with very low survival rates, Sellas aims higher
PharmaVoice
NOVEMBER 21, 2022
The company hopes its drugs can “take over where other available treatments fail” in multiple types of cancer.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Accelerated Approval to Mirvetuximab Soravtansine-gynx Granted by FDA
Drug Topics
NOVEMBER 21, 2022
This is the first FDA-approved ADC for platinum-resistant disease, according to ImmunoGen.
Why the biopharma ‘IPO playbook’ changed in 2022
PharmaVoice
NOVEMBER 21, 2022
Biopharma IPOs have puttered in 2022, particularly compared to the record-breaking previous year, but they might be set to rebound.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
First-in-human gene therapy trial for major cardiac syndrome
European Pharmaceutical Review
NOVEMBER 21, 2022
The first-in-human gene therapy trial for heart failure patients with preserved ejection fraction (HFpEF) has been approved by the US Food & Drug Administration (FDA). SRD-001, the adenovirus associated virus (AAV)-based gene therapy is delivered to cardiac ventricular muscle cells via an intracoronary infusion system (produced by Sardocor, a clinical-stage gene therapy subsidiary of Medera), to increase the protein expression and functional activity of sarcoplasmic reticulum calcium ATPase
New Tool Developed to Track How Breast Cancer Grows
Pharmacy Times
NOVEMBER 21, 2022
New system combines computational and experimental techniques to map evolutionary cancer lineages in their natural habitat of human tissue.
Can a formal needs assessment simplify Speaker Bureau compliance?
PharmaVoice
NOVEMBER 21, 2022
In the biopharmaceutical industry, phases of innovation and change are often driven by regulatory action.
House lawmakers press Biden admin to change latest surprise billing rule
Fierce Healthcare
NOVEMBER 21, 2022
House lawmakers press Biden admin to change latest surprise billing rule. rking. Mon, 11/21/2022 - 17:18.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Smoking, Insurance Coverage Show Link in Those With Mental Health Disorders, SUD
Pharmacy Times
NOVEMBER 21, 2022
The objective of the study was to estimate recent trends in cigarette use and health insurance coverage for US adults with and without mental health and SUD.
Provention prices type 1 diabetes drug Tzield at $194,000
pharmaphorum
NOVEMBER 21, 2022
Provention Bio has priced its new type 1 diabetes (T1D) prevention therapy Tzield at $13,850 per vial – equivalent to almost $194,000 for its 14-day course – a higher level than had been predicted by industry observers. The company argues that the cost is justified as Tzield (teplizumab) is the first drug that can delay the onset of type 1 diabetes, fending off the time when they become highly reliant on insulins and at risk of the serious complications that can accompany advanced T1D.
Growing Need for Mental Health Care Straining Existing Resources
Pharmacy Times
NOVEMBER 21, 2022
Demand for treatment of anxiety and depression remained high for the third consecutive year as the demand for the treatment of trauma- and stressor-related and substance use disorders has increased.
Therapeutic-first for cold agglutinin disease haemolytic anaemia
European Pharmaceutical Review
NOVEMBER 21, 2022
The European Commission (EC) has granted marketing authorisation for Enjaymo ® ( sutimlimab ), as the only approved treatment of haemolytic anaemia in adults with cold agglutinin disease (CAD). Enjaymo ® , Sanofi’s first-in-class humanised monoclonal antibody (mAb) is designed to inhibit the classical complement pathway specific serine protease, C1s, to prevent the abnormal destruction of healthy red blood cells.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Study: Significant New Onset Morbidity Observed in Children, Adolescents, Adults Following COVID-19 Infection
Pharmacy Times
NOVEMBER 21, 2022
Although long-term health issues from COVID-19 are a major public health concern, evidence on post-acute COVID-19 syndrome, or post-COVID-19, is still limited, specifically among children and adolescents.
How infectious disease experts are responding to Covid nearly three years in
STAT
NOVEMBER 21, 2022
The world is fast approaching the third anniversary of those days when we got our first inkling that a new disease was spreading in China. In the months that followed, normal life was suspended, then upended. At this point, everyone is well and truly sick of Covid-19 and the accommodations we have had to make to co-exist with it. So sick of it, in fact, that many people appear to have given up trying to avoid the SARS-CoV-2 virus.
Post-COVID-19 Symptoms Not Worse Among Hospitalized Patients Compared to Non-hospitalized Patients
Pharmacy Times
NOVEMBER 21, 2022
Approximately 2 years after patients were infected with COVID-19, non-hospitalized patients suffered from post-COVID-19 symptoms nearly 8% more than hospitalized patients.
DOJ to appeal UnitedHealth-Change Healthcare merger challenge
Fierce Healthcare
NOVEMBER 21, 2022
DOJ to appeal UnitedHealth-Change Healthcare merger challenge. pminemyer. Mon, 11/21/2022 - 07:37.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Rite Aid opens small-format pharmacy in Virginia
Drug Store News
NOVEMBER 21, 2022
The retailer opened its first small-format Rite Aid Pharmacy location, in Craigsville, Va., as part of a pilot program to improve access to pharmacy services.
mRNA revolutionized the race for a Covid-19 vaccine. Could cancer be next?
STAT
NOVEMBER 21, 2022
This story has been adapted from the STAT Report “The future of messenger RNA: Covid-19 vaccines are just the beginning.” The unprecedented success of messenger RNA vaccines against the coronavirus is raising hopes that the technology could lead to new and better vaccines against a much older public health scourge: cancer.
Stuffed Puffs, Cinnamon Toast Crunch add cereal-coated twist to marshmallows
Drug Store News
NOVEMBER 21, 2022
The Marshmallows are filled with real Cinnamon Toast Crunch crème, the companies said.
The case for universal oral health coverage, according to a new WHO report
STAT
NOVEMBER 21, 2022
On Friday, oral health advocates across the globe got an early holiday gift from their longtime wish lists. They had been waiting their whole careers — for some STAT spoke with, up to nearly half a century — for oral health to be folded into conversations calling for health care access for all. The World Health Organization’s new Global Oral Health Status report took that first step.
MegaFood updates packaging on key product lines
Drug Store News
NOVEMBER 21, 2022
Designed to keep its key visual elements, the new product layout includes enhanced readability of product names and varieties.
Compare Medicare Advantage Plans
The Checkup by Singlecare
NOVEMBER 21, 2022
What are Medicare Advantage Plans? | Enrollment Periods | Types of Medicare Advantage plans | How to compare plans | Best plans | Lowering costs. Medicare Advantage (Part C) plans continue to improve their coverage and become more popular. Medicare Part C plans may have certain advantages over Original Medicare, such as additional services and protections, but there may also be disadvantages.
Billie Eilish’s 2nd fragrance takes dark, alluring turn
Drug Store News
NOVEMBER 21, 2022
Eilish No. 2, inspired by a darker, rainy world, contains sultry woody floral notes.
Watch: This small-town pharmacy may be a model for more affordable drugs
STAT
NOVEMBER 21, 2022
STAUNTON, Va. — Honest Rx operates like any other pharmacy in the United States — with one big exception. It does not accept health insurance. Pharmacist and owner Matthew Garner opened his business in 2022, after over 20 years of working in and managing other pharmacies. In that time, companies like CVS have become behemoths by merging with pharmacy benefit managers and insurers.
IT Infrastructure in the Current Life Science Company Environment
ISPE
NOVEMBER 21, 2022
IT Infrastructure in the Current Life Science Company Environment. Trudy Patterson. Mon, 11/21/2022 - 10:06. iSpeak Blog. iSpeak. IT Infrastructure in the Current Life Science Company Environment. Christopher J. Reid. Arthur D. Perez, PhD. 21 November 2022. A look through the lens of GAMP 5® Second Edition. IT Infrastructure is a broad term that encompasses both the platforms upon which business applications run, as well as the services that keep these platforms and applications running.
Sporting night vision goggles, a scientist probes the internal clocks that help parasites infect people
STAT
NOVEMBER 21, 2022
In the 1700s, French astronomer Jean-Jacques d’Ortous de Mairan noticed that the leaves of the mimosa plant opened towards the sun and closed at dusk. His discovery was in keeping with thousands of years of observations. But de Mairan also found that the plant followed the same rhythm even in the constant darkness of a cupboard, suggesting that some innate metronome kept the plant in sync with the rotation of the earth.
Walmart kicks off Spark Good Round Up campaign
Drug Store News
NOVEMBER 21, 2022
Walmart's Spark Good giving campaign will run Nov. 25 through Dec. 25.
STAT+: A CEO’s plan to monetize health data rescued from IBM Watson’s wreckage
STAT
NOVEMBER 21, 2022
A company being built from the ashes of IBM’s Watson Health division is launching new lines of business with a much different message: The real value is in the health data, not the fancy AI engine it might eventually power. The new venture, dubbed Merative, will focus on distributing data through channels designed to maximize its value for health plans, providers, pharmaceutical companies, employers and other businesses.
Walmart healthcare exec Pegus departs for Morgan Health
Fierce Healthcare
NOVEMBER 21, 2022
Walmart healthcare exec Pegus departs for Morgan Health. pminemyer. Mon, 11/21/2022 - 16:17.
The race for a new class of antibiotics
European Pharmaceutical Review
NOVEMBER 21, 2022
A study on the surge of new antimicrobial research has shown that despite almost a quarter of a million research papers (227,808) being published on the 12 bacterial families in the World Health Organization (WHO) global priority pathogen list of antibiotic-resistant bacteria from 2017, no new class of antibiotics has gone to market since 1987. Study data from Elsevier’s abstract and citation database Scopus, identified that 2,450 papers were published in 2021 on the pathogen WHO identified as m
What is Medigap?
The Checkup by Singlecare
NOVEMBER 21, 2022
What are Medigap plans? | Medigap vs. Medicare Advantage | Costs | How to enroll | FAQs . If you have recently enrolled in Medicare, you may have heard of Medigap plans and wondered how they work. Medigap policies , also known as Medicare Supplement policies, help cover some out-of- pocket costs associated with Original Medicare. There are multiple types of Medigap policies to choose from that fit your medical and financial needs.
Let's personalize your content